Bitcoin L2s could start a liquidity war this month, KuCoin report suggests
KuCoin report indicates a 'battle for liquidity' among Bitcoin L2s as Merlin Chain hits a TVL peak and Stacks nears its Nakamoto upgrade. The post Bitcoin L2s could start a liquidity war this month, KuCoin report suggest...
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
KuCoin report indicates a 'battle for liquidity' among Bitcoin L2s as Merlin Chain hits a TVL peak and Stacks nears its Nakamoto upgrade.
The post Bitcoin L2s could start a liquidity war this month, KuCoin report suggests appeared first on Crypto Briefing.
Why this matters
This bitcoin story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on Crypto BriefingRelated market context
Major SEC Crypto Rule Coming This Month, Updated Agenda Suggests
The U.S. Securities and Exchange Commission is preparing to propose a major crypto-specific rule as soon as this month, a move tha...
Solana’s $8.7B RWA surge shows tokenized assets are finally starting to move
Solana’s real-world asset transfer volume more than doubled over the past month, giving the network a stronger signal that tokeniz...
KuCoin UAE Alliance Deal Points To The Gulf’s Growing Crypto Infrastructure Ambitions
The Gulf’s crypto ambitions are not slowing down. KuCoin’s partnership with a UAE crypto alliance adds another exchange-level move...
Mobile app Toss and blockchain Optimism to conduct Korean won stablecoin POC : report
Toss has reportedly partnered with Optimism and Sunnyside Labs for a proof of concept on the feasibility of a Korean won-based sta...
Kraken WEMIX Listing Gives Gaming Token A Fresh Liquidity Window
Kraken’s WEMIX listing is not just another token notice for traders who follow gaming assets. It gives the project a larger regula...
Nasdaq arthritis company holding Moshe Hogeg crypto hits all-time low
As of 8:19am today in New York, every retail investor who had ever bought shares of Enlivex on the Nasdaq, an arthritis biotech-tu...